📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Applying switchable Cas9 variants to in vivo gene editing for therapeutic applications (2019)

First Author: Mills E

Attributed to: Switchable gene drives funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s10565-019-09488-2

PubMed Identifier: 31418127

Publication URI: http://europepmc.org/abstract/MED/31418127

Type: Journal Article/Review

Parent Publication: Cell Biology and Toxicology

Issue: 1

ISSN: 0742-2091